Serum retinol-binding protein-4 levels are increased in HIV-infected subjects with metabolic syndrome receiving highly active antiretroviral therapy

Su Jin Jeong, Bum Sik Chin, Yun Tae Chae, Sung Joon Jin, Nam Su Ku, Ji Hyeon Baek, Sang Hoon Han, Chang Oh Kim, JunYong Choi, Young Goo Song, Hyun Chul Lee, June Myung Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Metabolic syndrome is an important long term complication in chronic asymptomatic HIV-infected subjects under highly active antiretroviral therapy (HAART), because it can contribute to morbidity and mortality via cardiovascular disease (CVD). Therefore, a predictive marker for early detection of metabolic syndrome may be necessary to prevent CVD in HIV-infected subjects. Retinol-binding protein- 4 (RBP-4) has been shown to be associated with metabolic syndrome in various non-HIV-infected populations. We performed a cross-sectional study to evaluate whether serum RBP-4 levels are correlated with metabolic syndrome in HIV-infected subjects receiving HAART. In total, 98 HIV-infected Koreans who had been receiving HAART for at least 6 months were prospectively enrolled. Metabolic syndrome was diagnosed according to the Adult Treatment Panel III criteria, and serum RBP-4 concentrations were measured using human RBP-4 sandwich enzyme- linked immunosorbent assay. Serum RBP-4 levels were significantly higher in HIV-infected subjects receiving HAART with metabolic syndrome (n=33, 33.9±7.7 μg/mL) than in those without it (n=65, 29.9±7.2 μg/mL) (p=0.012). In multivariate linear regression analysis, the number of components of metabolic syndrome presented and waist circumference were independently, significantly correlated with RBP-4 (p=0.018 and 0.030, respectively). In conclusion, we revealed a strong correlation between RBP-4 and the number of components of metabolic syndrome in HIV-infected subjects receiving HAART.

Original languageEnglish
Pages (from-to)1211-1215
Number of pages5
JournalYonsei medical journal
Volume53
Issue number6
DOIs
Publication statusPublished - 2012 Nov 1

Fingerprint

Retinol-Binding Proteins
Highly Active Antiretroviral Therapy
HIV
Serum
Cardiovascular Diseases
Waist Circumference
Linear Models
Cross-Sectional Studies
Enzyme-Linked Immunosorbent Assay
Regression Analysis
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Jeong, Su Jin ; Chin, Bum Sik ; Chae, Yun Tae ; Jin, Sung Joon ; Ku, Nam Su ; Baek, Ji Hyeon ; Han, Sang Hoon ; Kim, Chang Oh ; Choi, JunYong ; Song, Young Goo ; Lee, Hyun Chul ; Kim, June Myung. / Serum retinol-binding protein-4 levels are increased in HIV-infected subjects with metabolic syndrome receiving highly active antiretroviral therapy. In: Yonsei medical journal. 2012 ; Vol. 53, No. 6. pp. 1211-1215.
@article{67005109c3a1400d8d58a6561c573e60,
title = "Serum retinol-binding protein-4 levels are increased in HIV-infected subjects with metabolic syndrome receiving highly active antiretroviral therapy",
abstract = "Metabolic syndrome is an important long term complication in chronic asymptomatic HIV-infected subjects under highly active antiretroviral therapy (HAART), because it can contribute to morbidity and mortality via cardiovascular disease (CVD). Therefore, a predictive marker for early detection of metabolic syndrome may be necessary to prevent CVD in HIV-infected subjects. Retinol-binding protein- 4 (RBP-4) has been shown to be associated with metabolic syndrome in various non-HIV-infected populations. We performed a cross-sectional study to evaluate whether serum RBP-4 levels are correlated with metabolic syndrome in HIV-infected subjects receiving HAART. In total, 98 HIV-infected Koreans who had been receiving HAART for at least 6 months were prospectively enrolled. Metabolic syndrome was diagnosed according to the Adult Treatment Panel III criteria, and serum RBP-4 concentrations were measured using human RBP-4 sandwich enzyme- linked immunosorbent assay. Serum RBP-4 levels were significantly higher in HIV-infected subjects receiving HAART with metabolic syndrome (n=33, 33.9±7.7 μg/mL) than in those without it (n=65, 29.9±7.2 μg/mL) (p=0.012). In multivariate linear regression analysis, the number of components of metabolic syndrome presented and waist circumference were independently, significantly correlated with RBP-4 (p=0.018 and 0.030, respectively). In conclusion, we revealed a strong correlation between RBP-4 and the number of components of metabolic syndrome in HIV-infected subjects receiving HAART.",
author = "Jeong, {Su Jin} and Chin, {Bum Sik} and Chae, {Yun Tae} and Jin, {Sung Joon} and Ku, {Nam Su} and Baek, {Ji Hyeon} and Han, {Sang Hoon} and Kim, {Chang Oh} and JunYong Choi and Song, {Young Goo} and Lee, {Hyun Chul} and Kim, {June Myung}",
year = "2012",
month = "11",
day = "1",
doi = "10.3349/ymj.2012.53.6.1211",
language = "English",
volume = "53",
pages = "1211--1215",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "6",

}

Serum retinol-binding protein-4 levels are increased in HIV-infected subjects with metabolic syndrome receiving highly active antiretroviral therapy. / Jeong, Su Jin; Chin, Bum Sik; Chae, Yun Tae; Jin, Sung Joon; Ku, Nam Su; Baek, Ji Hyeon; Han, Sang Hoon; Kim, Chang Oh; Choi, JunYong; Song, Young Goo; Lee, Hyun Chul; Kim, June Myung.

In: Yonsei medical journal, Vol. 53, No. 6, 01.11.2012, p. 1211-1215.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum retinol-binding protein-4 levels are increased in HIV-infected subjects with metabolic syndrome receiving highly active antiretroviral therapy

AU - Jeong, Su Jin

AU - Chin, Bum Sik

AU - Chae, Yun Tae

AU - Jin, Sung Joon

AU - Ku, Nam Su

AU - Baek, Ji Hyeon

AU - Han, Sang Hoon

AU - Kim, Chang Oh

AU - Choi, JunYong

AU - Song, Young Goo

AU - Lee, Hyun Chul

AU - Kim, June Myung

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Metabolic syndrome is an important long term complication in chronic asymptomatic HIV-infected subjects under highly active antiretroviral therapy (HAART), because it can contribute to morbidity and mortality via cardiovascular disease (CVD). Therefore, a predictive marker for early detection of metabolic syndrome may be necessary to prevent CVD in HIV-infected subjects. Retinol-binding protein- 4 (RBP-4) has been shown to be associated with metabolic syndrome in various non-HIV-infected populations. We performed a cross-sectional study to evaluate whether serum RBP-4 levels are correlated with metabolic syndrome in HIV-infected subjects receiving HAART. In total, 98 HIV-infected Koreans who had been receiving HAART for at least 6 months were prospectively enrolled. Metabolic syndrome was diagnosed according to the Adult Treatment Panel III criteria, and serum RBP-4 concentrations were measured using human RBP-4 sandwich enzyme- linked immunosorbent assay. Serum RBP-4 levels were significantly higher in HIV-infected subjects receiving HAART with metabolic syndrome (n=33, 33.9±7.7 μg/mL) than in those without it (n=65, 29.9±7.2 μg/mL) (p=0.012). In multivariate linear regression analysis, the number of components of metabolic syndrome presented and waist circumference were independently, significantly correlated with RBP-4 (p=0.018 and 0.030, respectively). In conclusion, we revealed a strong correlation between RBP-4 and the number of components of metabolic syndrome in HIV-infected subjects receiving HAART.

AB - Metabolic syndrome is an important long term complication in chronic asymptomatic HIV-infected subjects under highly active antiretroviral therapy (HAART), because it can contribute to morbidity and mortality via cardiovascular disease (CVD). Therefore, a predictive marker for early detection of metabolic syndrome may be necessary to prevent CVD in HIV-infected subjects. Retinol-binding protein- 4 (RBP-4) has been shown to be associated with metabolic syndrome in various non-HIV-infected populations. We performed a cross-sectional study to evaluate whether serum RBP-4 levels are correlated with metabolic syndrome in HIV-infected subjects receiving HAART. In total, 98 HIV-infected Koreans who had been receiving HAART for at least 6 months were prospectively enrolled. Metabolic syndrome was diagnosed according to the Adult Treatment Panel III criteria, and serum RBP-4 concentrations were measured using human RBP-4 sandwich enzyme- linked immunosorbent assay. Serum RBP-4 levels were significantly higher in HIV-infected subjects receiving HAART with metabolic syndrome (n=33, 33.9±7.7 μg/mL) than in those without it (n=65, 29.9±7.2 μg/mL) (p=0.012). In multivariate linear regression analysis, the number of components of metabolic syndrome presented and waist circumference were independently, significantly correlated with RBP-4 (p=0.018 and 0.030, respectively). In conclusion, we revealed a strong correlation between RBP-4 and the number of components of metabolic syndrome in HIV-infected subjects receiving HAART.

UR - http://www.scopus.com/inward/record.url?scp=84868123820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868123820&partnerID=8YFLogxK

U2 - 10.3349/ymj.2012.53.6.1211

DO - 10.3349/ymj.2012.53.6.1211

M3 - Article

VL - 53

SP - 1211

EP - 1215

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 6

ER -